Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases, ...

For patients with cardiogenic shock transferring from a referring hospital, the median time to acceptance fell from 1.55 hours to 0.35 hours. The analysis indicated no differences in mortality ...

She transitioned from cyanosis and cardiogenic shock to regaining a healthy pink complexion ... particularly ...

Thiazolidinedione use was associated with lower risk for mortality and cardiorenal events among adults with type 2 diabetes and acute kidney disease.

In this paper, we introduce a data processing pipeline for cardiogenic ... for predicting cardiogenic shock (CS) in patients suffering from acute coronary syndrome (ACS) (11). Despite improvements in ...

Eva Maravelias began losing consciousness in her Toms River home in March 2024 and later found herself at Hackensack Meridian ...

Implantation of the Impella CP micro-axial flow pump may increase survival at six months among patients with STEMI complicated by cardiogenic shock (CS), according to the results ... Results showed ...

Most of the change in stage of cardiogenic shock (CS ... Noting that more than half of patients with stage B CS at baseline progressed in shock severity, they add that further study of these patients ...

Progress in assessing cardiovascular risk and identifying early prevention opportunities, improvements in treating heart failure, new therapies for bleeding strokes, strategies for reducing the ...

and results pertaining to all-cause mortality (ACM), cardiogenic shock (CS), length of stay (LOS), and hospitalization expense. Moreover, propensity score matching was conducted in a 1:1 ratio ...

poses significant challenges in cardiovascular management due to its high morbidity and mortality rates. Postcardiotomy cardiogenic shock (PCS) is a severe complication following ATAAD repair that ...